Product Introduction:
DALTONbio has developed the world's first products for the detection and screening of high-risk types of HPV based on its third-generation hybrid capture technology (DH series). The DH series products have served nearly 20 million women in China and neighboring countries in the past nine years. It is well-suited for cervical cancer detection and screening in high-, middle-, and low-income countries.
Bring better products and service for people's health
Contact Now